key: cord-0838572-0nioym64
authors: Ye, Qiaozhen; West, Alan M.V.; Silletti, Steve; Corbett, Kevin D.
title: Architecture and self‐assembly of the SARS‐CoV‐2 nucleocapsid protein
date: 2020-07-12
journal: Protein Sci
DOI: 10.1002/pro.3909
sha: 4e9f3bd35ee5f0000828117d9e0106b896a2fc21
doc_id: 838572
cord_uid: 0nioym64

The COVID‐2019 pandemic is the most severe acute public health threat of the twenty‐first century. To properly address this crisis with both robust testing and novel treatments, we require a deep understanding of the life cycle of the causative agent, the SARS‐CoV‐2 coronavirus. Here, we examine the architecture and self‐assembly properties of the SARS‐CoV‐2 nucleocapsid protein, which packages viral RNA into new virions. We determined a 1.4 å resolution crystal structure of this protein's N2b domain, revealing a compact, intertwined dimer similar to that of related coronaviruses including SARS‐CoV. While the N2b domain forms a dimer in solution, addition of the C‐terminal spacer B/N3 domain mediates formation of a homotetramer. Using hydrogen‐deuterium exchange mass spectrometry, we find evidence that at least part of this putatively disordered domain is structured, potentially forming an α‐helix that self‐associates and cooperates with the N2b domain to mediate tetramer formation. Finally, we map the locations of amino acid substitutions in the N protein from over 38,000 SARS‐CoV‐2 genome sequences. We find that these substitutions are strongly clustered in the protein's N2a linker domain, and that substitutions within the N1b and N2b domains cluster away from their functional RNA binding and dimerization interfaces. Overall, this work reveals the architecture and self‐assembly properties of a key protein in the SARS‐CoV‐2 life cycle, with implications for both drug design and antibody‐based testing. This article is protected by copyright. All rights reserved.

SARS-CoV-2 1,2 is the third coronavirus to cross from an animal reservoir to infect humans in the 21 st century, after SARS (severe acute respiratory syndrome coronavirus) 3, 4 and MERS (Middle-East respiratory syndrome coronavirus). 5 Isolation and sequencing of SARS-CoV-2 was reported in January 2020, and the virus was found to be highly related to SARS and share a probable origin in bats. 2, 6 Since its emergence in December 2019 in Wuhan, China, the virus has infected over 10.5 million people and caused more than 500,000 deaths as of July 1, 2020 (https://coronavirus.jhu.edu). The high infectivity of SARS-CoV-2 and the worldwide spread of this ongoing outbreak highlight the urgent need for public health measures and therapeutics to limit new infections. Moreover, the severity of the atypical pneumonia caused by SARS-CoV-2 (COVID-2019), often requiring multi-week hospital stays and the use of invasive ventilators, [7] [8] [9] highlights the need for therapeutics to lessen the severity of individual infections.

Current therapeutic strategies against SARS-CoV-2 target major points in the life-cycle of the virus. The antiviral Remdesivir, first developed against Ebola virus, 10, 11 inhibits the viral RNAdependent RNA polymerases of a range of coronaviruses including SARS-CoV-2 [12] [13] [14] and has shown promise against SARS-CoV-2 in small-scale trials in both primates and humans. 15, 16 Another target is the viral protease (Mpro/3CLpro), which is required to process viral polyproteins into their active forms. 17 Finally, the transmembrane spike (S) glycoprotein mediates binding to host cells through the angiotensin converting enzyme 2 (ACE2) and

This article is protected by copyright. All rights reserved.

transmembrane protease, serine 2 (TMPRSS2) proteins, and mediates fusion of the viral and host cell membranes. [18] [19] [20] [21] As the most prominent surface component of the virus, the spike protein is the major target of antibodies in patients, and is the focus of several current efforts at SARS-CoV-2 vaccine development. Initial trials using antibody-containing plasma of convalescent COVID-19 patients has also shown promise in lessening the severity of the disease. 22 While the above efforts target viral entry, RNA synthesis, and protein processing, there has so far been less emphasis on other steps in the viral life cycle. One critical step in coronavirus replication is the assembly of the viral genomic RNA and nucleocapsid (N) protein into a ribonucleoprotein (RNP) complex, which interacts with the membrane (M) protein and is packaged into virions. Electron microscopy analysis of related betacoronaviruses has suggested that the RNP complex adopts a helical filament structure, 23-28 but recent cryo-electron tomography analysis of intact SARS-CoV-2 virions has revealed a beads-on-a-string like arrangement of globular RNP complexes that sometimes assemble into stacks resembling helical filaments. 29 Despite its location within the viral particle rather than on its surface, patients infected with SARS-CoV-2 show higher and earlier antibody responses to the nucleocapsid protein than to the surface spike protein. 30, 31 As such, a better understanding of the SARS-CoV-2 N protein's structure, and structural differences between it and N proteins of related coronaviruses including SARS-CoV, may aid the development of sensitive and specific immunological tests.

Coronavirus N proteins possess a shared domain structure with an N-terminal RNA-binding domain and a C-terminal domain responsible for dimerization. The assembly of the N protein into higher-order RNP complexes is not well understood, but likely involves cooperative interactions between the dimerization domain and other regions of the protein, plus the bound RNA. [32] [33] [34] [35] [36] [37] [38] [39] [40] Here, we present a high-resolution structure of the SARS-CoV-2 N dimerization domain, revealing an intertwined dimer similar to that of related betacoronaviruses. We also analyze the self-assembly properties of the SARS-CoV-2 N protein, and show that higher-order assembly requires both the dimerization domain and the extended, disordered C-terminus of the protein. Together with other work revealing the structure and RNA-binding properties of the nucleocapsid N-terminal domain, these results lay the groundwork for a comprehensive understanding of SARS-CoV-2 nucleocapsid assembly and architecture.

Betacoronavirus nucleocapsid (N) proteins share a common overall domain structure, with ordered RNA-binding (N1b or N-terminal domain/NTD) and dimerization (N2b or C-terminal This article is protected by copyright. All rights reserved. domain/CTD) domains separated by short regions with high predicted disorder [N1a, N2a, and spacer B/N3; Fig. 1(A) ]. Self-association of the full-length SARS-CoV N protein and the isolated C-terminal region (domains N2b plus spacer B/N3; residues 210-422) was first demonstrated by yeast two-hybrid analysis, 32 and the purified full-length protein was shown to self-associate into predominantly dimers in solution. 33 The structures of the N2b domain of SARS-CoV and several related coronaviruses confirmed the obligate homodimeric structure of this domain, [34] [35] [36] [37] [38] [39] [40] and other work showed that the region C-terminal to this domain mediates further self-association into tetramer, hexamer, and potentially higher oligomeric forms. [41] [42] [43] Other studies have suggested that the protein's N-terminal region, including the RNA-binding N1b domain, can also self-associate, 44, 45 highlighting the possibility that assembly of full-length N into helical filaments is mediated by cooperative interactions among several interfaces. To characterize the structure and self-assembly properties of the SARS-CoV-2 nucleocapsid, we first cloned and purified the protein's N2b dimerization domain (N2b; residues 247-364). 46, 47 We crystallized and determined two high-resolution crystal structures of N2b; a 1.45 Å resolution structure of His6-tagged N2b at pH 8.5, and a 1.42 Å resolution structure of N2b after His6-tag cleavage, at pH 4.5 (see Materials and Methods and Table S1 ). These structures reveal a compact, tightly intertwined dimer with a central four-stranded β-sheet comprising the bulk of the dimer interface [ Fig. 1 (B) ]. This interface is composed of two β-strands and a short α-helix from each protomer that extend toward the opposite protomer and pack against its This article is protected by copyright. All rights reserved. The structure of N2b closely resembles that of related coronaviruses, including SARS-CoV, Infectious Bronchitis Virus (IBV), MERS-CoV, and HCoV-NL63. [34] [35] [36] [37] [38] [39] The structure is particularly similar to that of SARS-CoV, with which the N2b domain shares 96% sequence identity; only five residues differ between these proteins' N2b domains (SARS-CoV Gln268  SARS-CoV-2 A267, D291E290, H335Thr334, Gln346Asn345, and Asn350Gln349), and the structures are correspondingly similar with an overall Cα r.m.s.d of 0.314 Å across the N2b dimer [ Fig. 1 

A crystal structure of the SARS-CoV N protein revealed a helical assembly of N2b domain dimers that was proposed as a possible structure for the observed helical nucleocapsid filaments in This article is protected by copyright. All rights reserved.

virions. 34 We therefore examined the packing of N2b domain dimers in the six crystal structures of this domain, five of which show distinct space groups and unit cell parameters. We identified two dimer-dimer packing modes that appear in multiple crystal forms, with packing mode 1 appearing in five structures, and packing mode 2 appearing in four [ Fig. S1 (B) ]. Neither of these packing modes would result in the assembly of a helical filament if repeated, nor do the dimerdimer interfaces strongly correlate with conserved surfaces on the N2b domain. This evidence, combined with our finding that N2b forms solely dimers in solution (see below), suggests that packing of N2b domain dimers does not underlie higher-order assembly of SARS-CoV-2 N protein filaments.

Since the first genome sequence of SARS-CoV-2 was reported in January 2020, 2 Table S2 ]. While many of these substitutions arise only once in our dataset and may therefore reflect errors in sequencing or sequence assembly, most likely reflect true variation among circulating strains of SARS-CoV-2. As a whole, the reported substitutions are enriched in the three intrinsically disordered domains (N1a, N2a, and spacer B/N3), with a particularly high density of substitutions in the serine/arginine-rich subdomain of N2a [SR in Fig. 2 

Our structures of the SARS-CoV-2 N protein N2b domain reveal that, as in related coronaviruses, this domain mediates homodimer formation. We next systematically investigated the molecular basis for higher-order self-assembly of the SARS-CoV-2 nucleocapsid. We first purified the full-length N protein (NFL) for analysis of its oligomeric state. This article is protected by copyright. All rights reserved.

To determine the molecular basis for homotetramer assembly, we purified a series of truncation constructs encompassing the ordered N1b and N2b domains and their associated linker domains [N1a, N2a, and spacer B/N3; Fig. 1 Finally, we analyzed the contribution of the C-terminal spacer B/N3 region to N protein selfassembly. Prior work with the Murine Hepatitis Virus (MHV) N protein showed that this region can, on its own, incorporate into nucleocapsid structures that lack the associated Membrane (M) protein, suggesting that the region mediates a homotypic interaction between N proteins. 47 Other work with SARS-CoV and HCoV-229E N proteins also found that the C-terminal spacer B/N3 region is required for higher-order assembly of tetramers and larger oligomers. [41] [42] [43] We purified a construct encoding N2b and the spacer B/N3 region (N2b3, residues 247-419) and

found that it forms a homotetramer [ Fig. 3 (E) ]. We also analyzed self-assembly of the spacer B/N3 region on its own by performing SEC-MALS analysis on this isolated region (N3, residues 365-419) fused to a His6-maltose binding protein (MBP) tag. Initial purification of His6-MBP-N3 yielded two peaks on the final size exclusion column, which we separated pooled and analyzed by SEC-MALS. We found that these two peaks correspond to a monomer and a dimer, respectively [ Fig. 3(F) ]. The pooled dimer population also showed a small population of potentially higher-order oligomers [ Fig. 3(F) ]. Together, these data suggest that assembly of betacoronavirus N protein filaments likely proceeds through at least three steps, each mediated by different oligomerization interfaces: (1) Compared to N2b, N2b3 contains an additional 56 amino acids (residues 365-419). While residues 360-394 were not detected in our HDX-MS analysis, we detected spectra for seven overlapping peptides spanning residues 395-419 at the protein's extreme C-terminus [ Fig. 4 

This article is protected by copyright. All rights reserved. these peptides exhibited higher levels of exchange than the ordered N2b domain, peptides spanning the N-terminal part of this region (particularly residues 395-402) showed a degree of protection compared to those at the extreme C-terminus [residues 404-419; Fig. 4 (E) ]. This finding suggests that at least part of the spacer B/N3 domain possesses secondary structure and may mediate N2b3 tetramer formation. Indeed, a recent molecular dynamics simulation of the N3 domain suggests the existence of an α-helix spanning residues 400-411 in this domain, 50 and our own analysis using the PSI-PRED server 51 suggests an α-helix spanning residues 400-416 [ Fig. 1(A) ].

We next compared HDX-MS exchange rates of N2b versus N2b3 for peptides within the N2b domain. We reasoned that if the C-terminus of N2b3 mediates tetramer formation, it may do so by docking against a surface in the N2b domain, which may be detectable by reduced deuterium uptake in the involved region. Contrary to this expectation, we found that the H-D exchange rates within the N2b domain were nearly identical between the two constructs, varying at most 2% in fractional deuterium uptake in individual peptides ([ Fig. 4 (B) , 4 (D) ]. While these data do not rule out the possibility that the spacer B/N3 region docks against N2b, they nonetheless support our SEC-MALS data showing that spacer B/N3 independently selfassociates to mediate N protein tetramer formation. We attempted to test this idea by measuring the association of His6-MBP-N3 with N2b, N2b3, and NFL in a pulldown assay [ Fig.   S4 (B) ]. We were unable to detect binding of His6-MBP-N3 to any of these three constructs. As both N2b3 and NFL likely exist as pre-formed tetramers, their failure to interact with additional His6-MBP-N3 is not surprising. The inability of N2b to interact with His6-MBP-N3, however, is consistent with the idea that the spacer B/N3 domain self-interacts rather than binding the N2b domain. This article is protected by copyright. All rights reserved.

Given the importance of nucleocapsid-mediated RNA packaging to the viral life cycle, small molecules that inhibit nucleocapsid self-assembly or mediate aberrant assembly may be effective at reducing the severity of infections and the infectivity of patients. The high resolution of our crystal structures will enable their use in virtual screening efforts to identify such nucleocapsid assembly modulators. Given the high conservation of the N2b domain in betacoronaviruses, these assembly modulators may also be effective at countering related viruses including SARS-CoV. As SARS-CoV-2 is unlikely to be the last betacoronavirus to jump from an animal reservoir to humans, the availability of such treatments could drastically alter the course of future epidemics.

The SARS-CoV-2 genome has been subject to unprecedented scrutiny, with over 38,000 individual genome sequences deposited in public databases as of early June, 2020. We used this set of genome sequences to identify over 10,000 instances of amino acid substitutions in the N protein, and showed that these variants are strongly clustered in the protein's N2a linker domain. The ~650 substitutions we identified in the N1b and N2b domains were clustered away from these domains' RNA binding and dimerization interfaces, reflecting the functional importance of these surfaces. 

For size exclusion chromatography coupled to multi-angle light scattering (SEC-MALS), 100 µL purified proteins at 2-5 mg/mL were injected onto a Superdex 200 Increase 10/300 GL column (GE Life Sciences) in gel filtration buffer. Light scattering and refractive index profiles were This article is protected by copyright. All rights reserved. collected by miniDAWN TREOS and Optilab T-rEX detectors (Wyatt Technology), respectively, and molecular weight was calculated using ASTRA v. 6 software (Wyatt Technology).

H-D exchange experiments were conducted with a Waters Synapt G2S system. 5 µL samples containing 10 µM protein in gel filtration buffer were mixed with 55 µL of the same buffer made with D2O for several deuteration times (0 sec, 1 min, 2 min, 5 min, 10 min) at 15°C. The exchange was quenched for 2 min at 1°C with an equal volume of quench buffer (3M guanidine HCl, 0.1% formic acid). Proteins were cleaved with pepsin and separated by reverse-phase chromatography, then directed into a Waters SYNAPT G2s quadrupole time-of-flight (qTOF) mass spectrometer. Peptides were identified using PLGS version 2.5 (Waters, Inc.), deuterium uptake was calculated using DynamX version 2.0 (Waters Corp.), and uptake was corrected for back-exchange using DECA. 53 Uptake plots were generated in Prism version 8. The structure of His6-tagged N2b was determined by molecular replacement from the structure of untagged N2b, then manually rebuilt and refined as above. Data collection statistics, refinement statistics, and database accession numbers for diffraction data and final structures can be found in Table S1 . All structural figures were generated with PyMOL version 2.3.

Nickel pulldown assays were performed in buffer A plus 300 mM NaCl and 10 mM imidazole pH 8.0. Ten µg bait (His6-MBP-N3) was mixed with equal weights of each prey protein in 50 µl total reaction volume and incubated on ice for 30 minutes (5 µl "load" sample removed). 30 µl of a 50% slurry of Ni-NTA Superflow beads (Qiagen) was added and the mixture was incubated with occasional mixing on ice for 30 minutes. Beads were washed three times with 1 mL buffer, then bound proteins were eluted with the addition of 30 µl buffer A plus 300 mM NaCl and 250 mM imidazole pH 8.0. Ten µl of each eluate was analyzed by SDS-PAGE alongside the load samples.

To examine variation in SARS-CoV-2 sequences, we downloaded a list of variants in the N gene residue 204 identity, we used the URL "https://nextstrain.org/ncov/global?c=gt-N_204&l=unrooted" (screenshots taken July 2, 2020).

Supplementary material for this article includes four Supplemental Figures (Figures S1-S4 ) and

two Supplemental Tables (Tables S1 and S2 ). Figures S1-S4 and Table S1 can be found in the combined Supplementary Material PDF file, and Table S2 can be found in a separate Microsoft Excel file. Table S2 ). The most highly-mutated positions are R203 and G204, which are each mutated more than 4,000 times due to a prevalent trinucleotide substitution [ Fig. S2 . At left, blue indicates RNA-binding residues identified by NMR peak shifts (A50, T57, H59, R92, I94, S105, R107, R149, and Y172). 49 At right, two views colored by the number of variants at each position observed in a set of 38,318 SARS-CoV-2 genomes. The two most frequently-mutated residues are shown in stick view and labeled. Only one mutation (A50E, observed in one sequence) overlaps the putative RNA binding surface. This article is protected by copyright. All rights reserved.

A novel coronavirus from patients with pneumonia in China

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

A novel coronavirus associated with severe acute respiratory syndrome

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

Clinical characteristics of Covid-19 in

Clinical characteristics of coronavirus disease 2019 in China

Severe outcomes among patients with coronavirus disease 2019 (COVID-19) -United States

) for the treatment of Ebola and emerging viruses

Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir

Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease

The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus

Compassionate use of Remdesivir for patients with severe Covid-19

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved αketoamide inhibitors

Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Ribonucleoprotein of avian infectious bronchitis virus

Ribonucleoprotein-like structures from coronavirus particles

The molecular biology of coronaviruses

Molecular interactions in the assembly of coronaviruses

An overview of their replication and pathogenesis

Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion

SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography

Beyond the Spike: identification of viral targets of the antibody response to SARS-CoV-2 in COVID-19 patients

Detection of nucleocapsid antibody to SARS-CoV-2 is more sensitive than antibody to spike protein in COVID-19 patients

The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domain

In vitro biochemical and thermodynamic characterization of nucleocapsid protein of SARS

Structure of the SARS coronavirus nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for helical packaging of viral RNA

Crystal structure of the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein dimerization domain reveals evolutionary linkage between Corona-and Arteriviridae

Solution structure of the C-terminal dimerization domain of SARS coronavirus nucleocapsid protein solved by the SAIL-NMR method

X-Ray structures of the N-and C-terminal domains of a coronavirus nucleocapsid protein: Implications for nucleocapsid formation

Structure and oligomerization state of the C-terminal region of the Middle East respiratory syndrome coronavirus nucleoprotein

Structural characterization of human coronavirus NL63 N protein

Structures of the N-and C-terminal domains of MHV-A59 nucleocapsid protein corroborate a conserved RNA-protein binding mechanism in coronavirus

Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsid protein: Self-association analysis and nucleic acid binding characterization

Transient oligomerization of the SARS-CoV N protein -implication for virus ribonucleoprotein packaging

Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein

The nucleocapsid protein of coronavirus infectious bronchitis virus: Crystal structure of its N-terminal domain and multimerization properties

Coronavirus nucleocapsid proteins assemble constitutively in high molecular oligomers

An interaction between the nucleocapsid protein and a component of the replicase-transcriptase complex is crucial for the infectivity of coronavirus genomic RNA

Identification of in vivo-interacting domains of the murine coronavirus nucleocapsid protein

Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites

Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein

Holehouse AS (2020) The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA

Scalable web services for the PSIPRED Protein Analysis Workbench

Expression and purification of soluble His(6)-tagged TEV protease

DECA, a comprehensive, automatic post-processing program for HDX-MS data

How good are my data and what is the resolution?

Overview of the CCP4 suite and current developments

Phaser crystallographic software

Features and development of Coot

Towards automated crystallographic structure refinement with phenix.refine

Nextstrain: real-time tracking of pathogen evolution

Protein sequence alignments: a strategy for the hierarchical analysis of residue conservation

DISOPRED3: precise disordered region predictions with annotated protein-binding activity

Size exclusion chromatography (Superose 6 Increase 10/300 GL; void volume=8.4 mL, total volume=20.5 mL) coupled to multi-angle light scattering (SEC-MALS) analysis of full-length SARS-CoV-2 N. The measured MW of 190

See Figure S3(B) for SDS-PAGE analysis of all purified proteins

Increase 10/300 GL; void volume=7.3 mL, total volume=20.6 mL; used for panels B-F) coupled to multi-angle light scattering (SEC-MALS) analysis of SARS-CoV-2 N1ab (residues 2-175). The measured MW of 20.8 kDa closely matches that of a monomer

N1ab2a (residues 2-246). The measured MW of 25.0 kDa is slightly less than that of a monomer (26.2 kDa), reflecting partial proteolysis within the N2a domain

SEC-MALS analysis of SARS-CoV-2 N2b. The measured MW (31.5 kDa) closely matches that of a homodimer (26.5 kDa)

SEC-MALS analysis of SARS-CoV-2 N2b3. The measured MW (75.6 kDa) closely matches that of a homotetramer (77.4 kDa)

peak 1" black/dark blue; "peak 2" gray/light blue) The measured MW of peak 1 (101.9 kDa) and peak 2 (48.9 kDa) closely match those of a homodimer (101.7 kDa) and a monomer (50.9 kDa). The small peak at 10.5 mL suggests higherorder self-assembly

Schematic summary of size exclusion and SEC-MALS results on N protein constructs. See Figures S3(C) and S3(D) for SEC-MALS analysis of N1b (residues 49-174) and N1b2a (residues

Possible configurations of a SARS-CoV-2 N protein tetramer. Dimerization is mediated by the N2b domain, and these dimers self-associate through the N3 region to form homotetramers. Left: Parallel arrangement of the putative N3 domain α-helices

The authors thank the staff of Advanced Photon Source NE-CAT beamline 24ID-E for assistance This article is protected by copyright. All rights reserved.